Point72 Asset Management’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-160,725
| Closed | -$444K | – | 1834 |
|
|
2025
Q1 | $444K | Sell |
160,725
-1,091,116
| -87% | -$3.01M | ﹤0.01% | 1002 |
|
|
2024
Q4 | $6.94M | Sell |
1,251,841
-1,455,674
| -54% | -$8.06M | 0.02% | 621 |
|
|
2024
Q3 | $22.6M | Buy |
2,707,515
+17,139
| +0.6% | +$143K | 0.06% | 332 |
|
|
2024
Q2 | $18.3M | Buy |
2,690,376
+469,176
| +21% | +$3.2M | 0.05% | 374 |
|
|
2024
Q1 | $14.6M | Buy |
+2,221,200
| New | +$14.6M | 0.04% | 495 |
|
|
2023
Q4 | – | Sell |
-571,265
| Closed | -$2.87M | – | 2065 |
|
|
2023
Q3 | $2.87M | Buy |
+571,265
| New | +$2.87M | 0.01% | 789 |
|
|
2023
Q2 | – | Sell |
-629,098
| Closed | -$7.45M | – | 2155 |
|
|
2023
Q1 | $7.45M | Buy |
629,098
+395,598
| +169% | +$4.68M | 0.02% | 566 |
|
|
2022
Q4 | $2.38M | Buy |
+233,500
| New | +$2.38M | 0.01% | 742 |
|
|
2022
Q3 | – | Sell |
-500,000
| Closed | -$1.24M | – | 1363 |
|
|
2022
Q2 | $1.24M | Buy |
500,000
+377,427
| +308% | +$936K | 0.01% | 814 |
|
|
2022
Q1 | $364K | Buy |
+122,573
| New | +$364K | ﹤0.01% | 940 |
|